Sasha Taleban1,2, Nima Toosizadeh3,4,5, Shilpa Junna3, Todd Golden4, Sehem Ghazala3, Rita Wadeea3, Coco Tirambulo4, Jane Mohler3,4,5. 1. College of Medicine, University of Arizona, 1501 N. Campbell Ave, Tucson, AZ, 85718, USA. staleban@deptofmed.arizona.edu. 2. Arizona Center on Aging, University of Arizona, Tucson, AZ, USA. staleban@deptofmed.arizona.edu. 3. College of Medicine, University of Arizona, 1501 N. Campbell Ave, Tucson, AZ, 85718, USA. 4. Arizona Center on Aging, University of Arizona, Tucson, AZ, USA. 5. College of Engineering, University of Arizona, Tucson, AZ, USA.
Abstract
BACKGROUND: Colonoscopy is associated with multiple adverse outcomes. With an aging population undergoing colorectal cancer screening, few modalities exist to assess the patient risk prior to colonoscopy. Frailty, the age-related decline in reserve and function across multiple organ systems, predicts poor surgical outcomes, but its role in endoscopy is unclear. AIMS: This prospective cohort study assesses the efficacy of frailty in predicting acute colonoscopy outcomes. METHODS: Participants aged ≥ 50 years undergoing screening colonoscopy at a tertiary care center were recruited over 2 months ending in July 2017. Frailty was assessed using a validated 20-s upper-extremity frailty test, which measures the capacity of muscle performance. Demographic data, American Society of Anesthesiologists (ASA) status, and Charlson comorbidity index (CCI) were evaluated. Procedure-related adverse events and cardiopulmonary changes during and in the immediate post-procedure period were recorded. Adverse events were stratified into minor and major events. Chi-square and ANCOVA models were used in the analysis. RESULTS: Ninety-nine adults (mean age 62.8 years) were enrolled, among which 49 were non-frail and 50 were pre-frail/frail; 50 were female. Overall, 55 participants experienced a total of 87 adverse events. Frailty and ASA status were significantly associated with colonoscopy adverse events (p = 0.01 and p = 0.02, respectively). Age and CCI did not predict colonoscopy outcomes. CONCLUSIONS: Compared to age and CCI, frailty status better predicts colonoscopy outcomes in older adults. Among adults undergoing colonoscopy, routine frailty screening should be considered for risk stratification. Additional prospective studies evaluating frailty measurements in endoscopy will further clarify its role in forecasting adverse events.
BACKGROUND: Colonoscopy is associated with multiple adverse outcomes. With an aging population undergoing colorectal cancer screening, few modalities exist to assess the patient risk prior to colonoscopy. Frailty, the age-related decline in reserve and function across multiple organ systems, predicts poor surgical outcomes, but its role in endoscopy is unclear. AIMS: This prospective cohort study assesses the efficacy of frailty in predicting acute colonoscopy outcomes. METHODS:Participants aged ≥ 50 years undergoing screening colonoscopy at a tertiary care center were recruited over 2 months ending in July 2017. Frailty was assessed using a validated 20-s upper-extremity frailty test, which measures the capacity of muscle performance. Demographic data, American Society of Anesthesiologists (ASA) status, and Charlson comorbidity index (CCI) were evaluated. Procedure-related adverse events and cardiopulmonary changes during and in the immediate post-procedure period were recorded. Adverse events were stratified into minor and major events. Chi-square and ANCOVA models were used in the analysis. RESULTS: Ninety-nine adults (mean age 62.8 years) were enrolled, among which 49 were non-frail and 50 were pre-frail/frail; 50 were female. Overall, 55 participants experienced a total of 87 adverse events. Frailty and ASA status were significantly associated with colonoscopy adverse events (p = 0.01 and p = 0.02, respectively). Age and CCI did not predict colonoscopy outcomes. CONCLUSIONS: Compared to age and CCI, frailty status better predicts colonoscopy outcomes in older adults. Among adults undergoing colonoscopy, routine frailty screening should be considered for risk stratification. Additional prospective studies evaluating frailty measurements in endoscopy will further clarify its role in forecasting adverse events.
Authors: Jessica L Li; Martha A Henderson; Louis M Revenig; John F Sweeney; David A Kooby; Shishir K Maithel; Viraj A Master; Kenneth Ogan Journal: J Surg Res Date: 2016-03-22 Impact factor: 2.192
Authors: Amir Qaseem; Thomas D Denberg; Robert H Hopkins; Linda L Humphrey; Joel Levine; Donna E Sweet; Paul Shekelle Journal: Ann Intern Med Date: 2012-03-06 Impact factor: 25.391
Authors: L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie Journal: J Gerontol A Biol Sci Med Sci Date: 2001-03 Impact factor: 6.053
Authors: Douglas K Rex; C Richard Boland; Jason A Dominitz; Francis M Giardiello; David A Johnson; Tonya Kaltenbach; Theodore R Levin; David Lieberman; Douglas J Robertson Journal: Gastroenterology Date: 2017-06-09 Impact factor: 22.682
Authors: Carrie N Klabunde; Yingye Zheng; Virginia P Quinn; Elisabeth F Beaber; Carolyn M Rutter; Ethan A Halm; Jessica Chubak; Chyke A Doubeni; Jennifer S Haas; Aruna Kamineni; Marilyn M Schapira; Pamela M Vacek; Michael P Garcia; Douglas A Corley Journal: Am J Prev Med Date: 2016-06-22 Impact factor: 5.043
Authors: Charles J Kahi; Michelle van Ryn; Beth Juliar; Jennifer Schaffter Stuart; Thomas F Imperiale Journal: J Gen Intern Med Date: 2009-09-18 Impact factor: 5.128
Authors: Frank van Hees; J Dik F Habbema; Reinier G Meester; Iris Lansdorp-Vogelaar; Marjolein van Ballegooijen; Ann G Zauber Journal: Ann Intern Med Date: 2014-06-03 Impact factor: 25.391